- Supported exchanges /
- F /
- 2SE.F
SEQUANA MEDICAL N.V. (2SE F) stock market data APIs
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
SEQUANA MEDICAL N.V. Financial Data Overview
0.802 | |
0.802 | |
- | |
0.802 | |
0.802 | |
0.53-4.69 | |
39 738 K | |
40 244 K | |
434 K | |
0.835 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
SEQUANA MEDICAL N.V. Fundamental Data is available in our Financial Data APIs
- Net Revenue 434 K
- EBITDA -23 317 588
- Earnings Per Share -0.91
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get SEQUANA MEDICAL N.V. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get SEQUANA MEDICAL N.V. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: